Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Orgenesis licenses IP covering diabetes therapy

March 14, 2012 12:55 AM UTC

Tel Hashomer Medical Research Infrastructure and Services Ltd. (Tel Hashomer, Israel) granted Orgenesis Inc. (OTCBB:ORGS) an exclusive license to develop and commercialize IP covering functional autol...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article